March 24, 2025 03:06 PM EDT
Pharma
Law

Ab­b­Vie files trade se­crets suit against ADC com­peti­tor

Nicole DeFeudis

Editor

Ab­b­Vie has ac­cused a Gen­mab sub­sidiary of steal­ing trade se­crets to build a po­ten­tial com­peti­tor to its ovar­i­an can­cer treat­ment Ela­here.

In a

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Executive Director, Marketing

Celldex Therapeutics

Hampton, NJ, USA

TRENDING NOW

WuXi Bi­o­log­ics’ li­cens­ing deals help off­set Biose­cure threat in the US

Mer­ck strikes deal for heart drug, worth up to $2B, with Chi­na’s Hen­grui

An­oth­er im­munol­o­gy biotech emerges as Hill­star takes flight with $67M

Kezar toplines small Phase 2a dataset in au­toim­mune liv­er dis­ease

Oph­thal­mol­o­gy start­up Char­ac­ter Bio­sciences gets $93M for ge­net­ics-based ap­proach

GSK to re­search whether shin­gles vac­cine can cut de­men­tia risk

A service from the Financial Times